🔬 Vijaya Diagnostic Faces Volatile Session Despite Strong Q1 Performance

On 7 August 2026,

witnessed sharp intraday volatility following its Q1 FY27 earnings announcement. The stock initially rallied nearly 4.6% as investors reacted positively to the results, but the momentum faded through the session. The stock eventually slipped into negative territory, closing 1.37% lower on Friday and ending almost 3.8% below its intraday high. 📊 Q1 FY27 Highlights (Consolidated YoY): • Profit surged 37.6% to ₹53.1 crore from ₹38.6 crore. • Revenue jumped 22.8% to ₹231 crore from ₹188 crore. While the strong earnings triggered early buying interest, profit-booking and broader market dynamics weighed on the stock later in the day. Despite the volatile session, Vijaya Diagnostic has remained a notable outperformer in CY2026, with the stock advancing more than 27% year-to-date. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.